Friday 6 May 2022

COVID Vaccine Shows Effectiveness in Phase 1 Trial | City of Hope | targets both the spike and nucleocapsid proteins; Phase 2 clinical trial for immunocompromised cancer patients, who have difficulty producing antibodies and largely depend on T cells

COVID Vaccine Shows Effectiveness in Phase 1 Trial | City of Hope | targets both the spike and nucleocapsid proteins; Phase 2 clinical trial for immunocompromised cancer patients, who have difficulty producing antibodies and largely depend on T cells submitted by /u/shallah
[link] [comments]


from Health https://ift.tt/ldIb2ZL
via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)